Potential Risk of Birth Defects after Acitretin Discontinuation

Publisher： Karger

E-ISSN： 1421-9832|198|1|3-4

ISSN： 1018-8665

Source： Dermatology, Vol.198, Iss.1, 1999-02, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Is There a Reproductive Safety Risk in Male Patients Treated with Acitretin (Neotigason®/Soriatane®)?

By  

Dermatology, Vol. 205, Iss. 2, 2002-08 ,pp. : 105-107

Karger

Access to resources Recommend Favorite

Acrodermatitis Continua of Hallopeau Treated Successfully with Ustekinumab and Acitretin after Failure of Tumour Necrosis Factor Blockade and Anakinra

By  

Dermatology, Vol. 230, Iss. 2, 2014-11 ,pp. : 97-100

Karger

Access to resources Recommend Favorite

Rectal Bleeding following Acitretin Therapy for Discoid Lupus Erythematosus

By  

Dermatology, Vol. 211, Iss. 4, 2005-12 ,pp. : 385-385

Karger

Access to resources Recommend Favorite

Marginal Papular Acrokeratodermas: No Racial Limitations for a Clinical Spectrum That Responds to Acitretin

By  

Dermatology, Vol. 203, Iss. 1, 2001-09 ,pp. : 63-65

Karger

Access to resources Recommend Favorite

Pachyonychia Congenita (K16) with Unusual Features and Good Response to Acitretin

By  

Case Reports in Dermatology, Vol. 7, Iss. 2, 2015-08 ,pp. : 220-226

Karger

Access to resources Recommend Favorite